Olympian Clinical Research

NOVEMBER 16, 2022

In its early stages, HS often presents as a small, pea-sized lump in one place. More research is still needed to understand the causes of HS fully. Receiving an accurate and prompt diagnosis of HS is essential for developing a treatment plan and preventing it from worsening. Treatments for Hidradenitis Suppurativa.

Treatment 52

Treatment Clinical Research Immune Response Therapies 52

PPD

OCTOBER 17, 2024

In China, the high incidence of solid tumors is driving an urgent need for advanced therapies, spurring the push for new treatment approaches. Site selection presents barriers and opportunities As cell therapies expand in Asia-Pacific, areas with large hospitals are often the main hubs for innovation.

Therapies 52

Therapies Clinical Trials Clinical Research Trials 52

Conversations in Drug Development Trends

JANUARY 24, 2024

Much of what we discuss I covered in my presentation, “Leveraging Genetics to Support Rare Disease Clinical Trials,” at last year’s World Orphan Drug Congress (WODC) EU. One diagnostic example that I discussed in my presentation is autism.

Trials 75

Trials Disease Clinical Trials Clinical Research 75

Drug Target Review

JULY 12, 2023

Molecular-level biochemical assays like transcriptomics, genomics and proteomics have emerged as valuable tools for identifying potential targets in cancer treatment through deep cyclic inhibition (DCI). How does the DCI mechanism compare to the design of other drugs for cancer treatment?

Biochemical Assays 98

Biochemical Assays Treatment Bioinformatics Disease 98

The Pharma Data

MARCH 11, 2021

Eli Lilly and Company (NYSE: LLY) today announced that data from programs across its oncology portfolio and pipeline will be presented at the 2021 American Association for Cancer Research (AACR) Annual Meeting, to be held virtually April 10-15, 2021. Portfolio Highlights. Pipeline Highlights.

Research 52

Research Clinical Trials Trials FDA Approval 52

PPD

NOVEMBER 7, 2023

The underrepresentation of diverse groups in clinical research is an area of regulatory, scientific and industry focus, partly due to the recent U.S. Food and Drug Administration (FDA) draft guidance, “Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials.”

Clinical Trials 59

Clinical Trials Trials Clinical Research Disease 59

Olympian Clinical Research

DECEMBER 19, 2023

Understanding its triggers, identifying symptoms, exploring home remedies, and reviewing advanced medical treatments are crucial for effective management. With ongoing research and clinical trials , institutions like Olympian Clinical Research are at the forefront of finding innovative treatment options.

Clinical Research 52

Clinical Research Clinical Trials Treatment Immune Response 52

Conversations in Drug Development Trends

JUNE 21, 2024

The 2024 ASCO Annual Meeting from the American Society of Clinical Oncology is a fantastic platform for clinical researchers to discuss the latest advancements and challenges in oncology research. Currently, there are 12 approved ADC drugs, and several hundred more are in the development pipeline.

Clinical Trials 64

Clinical Trials Therapies Clinical Research Immune Response 64

The Pharma Data

SEPTEMBER 10, 2020

Full data from the Phase 3 CROWN study in lung cancer will be presented during the Presidential Symposium. Data to be presented include findings from the Phase 3 CROWN study of LORBRENA ® (lorlatinib)* in first-line ALK-positive non-small cell lung cancer (NSCLC), building on Pfizer’s extensive heritage in precision medicine research.

Therapies 52

Therapies Clinical Trials Production Trials 52

The Pharma Data

JANUARY 14, 2021

(NASDAQ: FPRX) today announced clinical results from the global, randomized, double-blind placebo-controlled Phase 2 FIGHT trial evaluating first-in-class targeted therapy bemarituzumab in advanced gastric or gastroesophageal junction (GEJ) cancer. The ASCO GI presentation slides are available on the company’s website. Wainberg, M.D.,

Trials 52

Trials Treatment Therapies Clinical Trials 52

Olympian Clinical Research

AUGUST 19, 2022

While these conditions cannot be cured, there are treatments available that may lessen the symptoms. In addition, clinical research may provide new information and breakthrough treatments. . Therefore finding treatment options that may help lessen the symptoms is important. . Treatment Options for Pediatric Eczema.

Clinical Research 52

Clinical Research Treatment Doctors Licensing 52

The Pharma Data

APRIL 12, 2022

20% variant allele frequency reduction – At the time of analysis with > 2 year follow up the survival estimate was 100% in patients who had improvements in bone marrow fibrosis or variant allele frequency – Results were presented at the American Association for Cancer Research annual meeting.

Medical Schools 52

Medical Schools Trials Disease Clinical Development 52

The Pharma Data

JANUARY 14, 2021

COHASSET, MA, January 14, 2021 /24-7PressRelease/ — Marquis Who’s Who, the world’s premier publisher of biographical profiles, is proud to present Harvey Leonard Dickstein, MD, with the Albert Nelson Marquis Lifetime Achievement Award. As a seasoned scientist, Dr. Dickstein spent significant time conducting research.

Laboratories 52

Laboratories Clinical Research Hospitals Pharmaceuticals 52

Olympian Clinical Research

DECEMBER 1, 2022

The type of psoriasis you experience can influence the symptoms and complications associated with your condition as well as the treatment plan that is right for you. Potential treatment options include phototherapy, corticosteroids, and oral medications. Guttate psoriasis usually responds well to topical treatments and phototherapy. .

Clinical Trials 52

Clinical Trials Doctors Clinical Research Treatment 52

Conversations in Drug Development Trends

MAY 30, 2024

Since marketing authorization for the first breakthrough treatment in 1994, the steady increase in clinical trials reflects the community’s commitment to finding effective ALS treatments despite the numerous hurdles associated with clinical trial design, from proof-of-concept to pivotal trials.

Treatment 81

Treatment Clinical Trials Small Molecule Therapies 81

Drug Target Review

MAY 7, 2024

However, some biomarkers may only be present in a minority of patients, requiring a large patient population to identify such markers. Moreover, the application of synthetic control arms presents the opportunity to transform the trial process itself. Not all biomarkers have a limited prevalence.

Disease 59

Disease Clinical Trials Clinical Pharmacology Trials 59

Conversations in Drug Development Trends

AUGUST 9, 2024

It broadens recruitment strategies, diversifies the patient population, and expands the study population, thus increasing access to potentially life-saving treatments. These trials increase the chances of success by enabling the early detection of effective treatments in defined populations and focusing efforts on the most promising options.

Trials 80

Trials Clinical Trials Regulations FDA 80

Olympian Clinical Research

MARCH 31, 2022

In order to receive the right treatment for your condition, it’s essential to know what type of anxiety you’re experiencing. These symptoms can cause impairment throughout one’s daily life, and GAD is diagnosed when three or more symptoms are present more days than not for at least six months. What is General Anxiety Disorder?

Clinical Research 52

Clinical Research Clinical Trials Treatment Research 52

PPD

JUNE 29, 2023

Although several corticosteroid treatments are available as first-line treatments, drug developers continue to seek more effective therapies to improve the wellbeing of those diagnosed with atopic dermatitis. But developing treatments for atopic dermatitis is complex and competitive.

Clinical Trials 52

Clinical Trials Trials Drug Development Clinical Research 52

The Pharma Data

JANUARY 12, 2021

a biopharmaceutical company focused on the development of first-in-class therapeutics for the treatment of cancer, today announced the completion of the Phase 1b clinical trial conducted by the NCI with its lead clinical candidate zotiraciclib (ZTR/TG02), a potent oral cyclin-dependent kinase 9 (CDK9) inhibitor.

Clinical Trials 52

Clinical Trials Trials Treatment Pharmaceuticals 52

The Pharma Data

OCTOBER 19, 2020

Two presentations will be delivered by Nanobiotix and two will be delivered by the University of Texas MD Anderson Cancer Center. The Company is also engaged in a broad, comprehensive clinical research collaboration with The University of Texas MD Anderson Cancer Center to further expand the NBTXR3 development program.

Clinical Trials 52

Clinical Trials Immune Response Trials Therapies 52

Olympian Clinical Research

SEPTEMBER 16, 2021

Plaque psoriasis presents itself as patches of red, raised skin covered with silvery scales, along with a red bulbous base. Psoriasis Treatment Options. Once psoriasis is diagnosed, treatment is determined based on the level of severity and if there is a presence of joint involvement, known as psoriatic arthritis.

Clinical Research 52

Clinical Research Therapies Clinical Trials Doctors 52

Conversations in Drug Development Trends

APRIL 25, 2024

These data highlight both the prevalence of post-surgical pain and the critical need for comprehensive, non-opioid treatments aimed at alleviating it. Understanding and managing post-surgical pain is pivotal in clinical research for improving patient outcomes and care strategies.

Clinical Trials 52

Clinical Trials Compliance Trials Clinical Research 52

Conversations in Drug Development Trends

OCTOBER 24, 2023

Most rare disease patient communities have one or more patient advocacy organizations (PAOs) whose missions include raising awareness, providing advocacy and support for these patients and their families, and working towards meaningful treatments for their community.

Clinical Trials 52

Clinical Trials Disease Therapies Drug Development 52

The Pharma Data

MARCH 23, 2022

The only large-scale prospective study in dermatology designed to generate key disease insights among Black, Hispanic, Asian, Indigenous and other people of color Study reinforces Janssen’s commitments to inclusive clinical research and addressing health inequities.

Pharmaceutical Companies 52

Pharmaceutical Companies Clinical Research Disease Therapies 52

Vial

JUNE 24, 2024

The fields of artificial intelligence (AI) and machine learning (ML) are increasingly influencing clinical research and development (R&D). Contract research organizations (CROs) and pharmaceutical companies can leverage these cutting-edge technologies to streamline clinical trials and introduce automation in drug discovery.

Clinical Trials 52

Clinical Trials Trials Clinical Research Treatment 52

PPD

SEPTEMBER 25, 2023

The PPD clinical research business of Thermo Fisher Scientific has surveyed more than 150 drug developers around the globe to gather annual data on trends in pharmaceutical research and development. In Asia , personalized and precision medicine has become the driving force behind transformative clinical trials.

Drug Development 104

Drug Development Clinical Trials Drugs Trials 104

PPD

JUNE 24, 2024

Explore the unique aspects of mega trials, the challenges they pose to vaccine developers, what the future holds for these large, complex trials, and how a partnership with an experienced provider of clinical research solutions can enable success.

Vaccine 97

Vaccine Trials Clinical Trials Laboratories 97

The Premier Consulting Blog

NOVEMBER 30, 2022

It can augment preclinical and clinical research through mechanistic and predictive investigations that would otherwise be impossible. Virtual patients are then generated who can be randomized to one or more cohorts to allow researchers to select treatment options.

Trials 52

Trials Clinical Research Treatment Disease 52

Conversations in Drug Development Trends

NOVEMBER 10, 2023

At this year’s annual Pain Therapeutics Summit , which took place in San Diego, CA, October 19 to 20th, I heard brilliant presentations on novel pain medication development, targeted discoveries, pain classifications, the NIH HEAL Initiative , trial designs, biomarkers, and others.

Clinical Trials 75

Clinical Trials Trials Compliance Treatment 75

Olympian Clinical Research

JULY 7, 2021

It’s perfectly normal for people to get nervous in certain social situations, such as someone who’s worried about an upcoming interview for a job or dreading a class presentation. The post Understanding The Signs & Symptoms Of Social Anxiety appeared first on Olympian Clinical Research. Social Anxiety & Avoidance.

Clinical Research 52

Clinical Research Clinical Trials Research Trials 52

Olympian Clinical Research

JULY 12, 2022

There are several types of depression, each with its own set of symptoms and recommended treatment methods. Major depressive disorder ( MDD ), also known as clinical depression, is characterized by a persistent feeling of sadness or emptiness lasting for at least two weeks. As a result, many people do not seek treatment.

Clinical Research 94

Clinical Research Doctors Treatment Research 94

Advarra

AUGUST 14, 2023

The clinical research industry is only becoming more complex and competitive as organizations are inundated with multiple trials and tight deadlines. The clinical trial process is both expensive and time-consuming, and ends more often in failure than success. of respondents reported they know what clinical trials are.

Clinical Trials 52

Clinical Trials Trials Clinical Research Research 52

The Pharma Data

JUNE 25, 2021

First-Time Disease-Free Survival Data to be Presented During Plenary Session at the 2021 ASCO Annual Meeting. We hope to build on this important research and provide new treatment options to kidney cancer patients.”. “As Europe and Japan in combination with axitinib for the first-line treatment of patients with advanced RCC.

Disease 52

Disease Therapies Treatment Medical Schools 52

The Pharma Data

SEPTEMBER 28, 2021

Overall survival data from KEYNOTE-355 are going to be presented at the ecu Society for Medical Oncology (ESMO) Congress 2021 on Sept. This positive CHMP opinion is a crucial breakthrough in bringing a replacement immunotherapy treatment option with KEYTRUDA to appropriate patients in Europe with metastatic triple-negative carcinoma.

Research Laboratories 52

Research Laboratories Clinical Research Treatment Disease 52

Precision for Medicine

MAY 24, 2023

CRO Leadership Awards recognize companies judged by customers as exceeding expectations BETHESDA, MD, May 25, 2023 – Precision for Medicine, the first biomarker-driven clinical research organization (CRO), announces its wide recognition in the 2023 CRO Leadership Awards.

Clinical Trials 40

Clinical Trials Clinical Research Science Trials 40

The Pharma Data

OCTOBER 1, 2021

Deucravacitinib demonstrated efficacy no matter baseline characteristics, including weight , disease severity and former treatment with biologic or non-biologic therapies. These data (Presentation #2857) are being presented today during the Late Breaking News Session from 3:45 – 4:45 p.m.

Disease 52

Disease Laboratories Clinical Pharmacology Treatment 52